Molecular differentiation between osteophytic and articular cartilage - clues for a transient and permanent chondrocyte phenotype

Osteoarthritis and Cartilage

Volumn 20, Issue 2, 2012, Pages 162-171

  Gelse, K ^a   Ekici, A B ^b   Cipa, F ^a,b   Swoboda, B ^b   Carl, H D ^b   Olk, A ^a   Hennig, F F ^a   Klinger, P ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chondrogenesis; Endochondral ossification; Gremlin 1; Hypertrophic chondrocyte; Microarray; Osteophyte

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ALDEHYDE DEHYDROGENASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 8B; CALGRANULIN A; CALGRANULIN B; CARBONATE DEHYDRATASE II; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGENASE 3; COMPLEMENTARY DNA; FRIZZLED PROTEIN; GELATINASE B; HYPOCALCIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LAMBDA CHAIN; LIPOPROTEIN LIPASE; OSTEOCALCIN; PARATHYROID HORMONE RELATED PROTEIN; RNA; SCLEROSTIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFERRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERSICAN; VON WILLEBRAND FACTOR; WNT PROTEIN; WNT1 PROTEIN;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; DNA DAMAGE; DNA DETERMINATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOPHYTE; OSTEOPHYTIC CHONDROCYTE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

AGED; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KNEE JOINT; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS, KNEE; OSTEOGENESIS; OSTEOPHYTE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84855825971     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.12.004     Document Type: Article

References (51)

1. Blanke M., Carl H.D., Klinger P., Swoboda B., Hennig F., Gelse K. Transplanted chondrocytes inhibit endochondral ossification within cartilage repair tissue. Calcif Tissue Int 2009, 85(5):421-433.
2. Henderson I.J., La Valette D.P. Subchondral bone overgrowth in the presence of full-thickness cartilage defects in the knee. Knee 2005, 12(6):435-440.
3. Kreuz P.C., Steinwachs M.R., Erggelet C., Krause S.J., Konrad G., Uhl M., et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 2006, 14(11):1119-1125.
4. Mithoefer K., Williams R.J., Warren R.F., Potter H.G., Spock C.R., Jones E.C., et al. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. JBone Joint Surg Am 2005, 87(9):1911-1920.
5. Van der Kraan P.M., van den Berg W.B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007, 15(3):237-244.
6. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. JCell Biochem 2006, 97(1):33-44.
7. Van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998, 6(5):306-317.
8. Van der Kraan P.M., Vitters E.L., van Beuningen H.M., van de Putte L.B., van den Berg W.B. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. JExp Pathol (Oxford) 1990, 71(1):19-31.
9. Nakase T., Miyaji T., Tomita T., Kaneko M., Kuriyama K., Myoui A., et al. Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage 2003, 11(4):278-284.
10. Gelse K., Soder S., Eger W., Diemtar T., Aigner T. Osteophyte development-molecular characterization of differentiation stages. Osteoarthritis Cartilage 2003, 11(2):141-148.
11. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001, 44(12):2777-2789.
12. Gelse K., Muhle C., Franke O., Park J., Jehle M., Durst K., et al. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 2008, 58(2):475-488.
13. Gelse K., Jiang Q.J., Aigner T., Ritter T., Wagner K., Poschl E., et al. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum 2001, 44(8):1943-1953.
14. Blaney Davidson E.N., Vitters E.L., van Beuningen H.M., van de Loo F.A., van den Berg W.B., van der Kraan P.M. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007, 56(12):4065-4073.
15. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002, 250(2):231-250.
16. Ying Y., Qi X., Zhao G.Q. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci U S A 2001, 98(14):7858-7862.
17. Ozkaynak E., Schnegelsberg P.N., Jin D.F., Clifford G.M., Warren F.D., Drier E.A., et al. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. JBiol Chem 1992, 267(35):25220-25227.
18. Merino R., Rodriguez-Leon J., Macias D., Ganan Y., Economides A.N., Hurle J.M. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 1999, 126(23):5515-5522.
19. Sun J., Zhuang F.F., Mullersman J.E., Chen H., Robertson E.J., Warburton D., et al. BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction. JBiol Chem 2006, 281(39):29349-29356.
20. Benazet J.D., Bischofberger M., Tiecke E., Goncalves A., Martin J.F., Zuniga A., et al. Aself-regulatory system of interlinked signaling feedback loops controls mouse limb patterning. Science 2009, 323(5917):1050-1053.
21. Shapiro F., Flynn E., Calicchio M.L. Molecular differentiation in epiphyseal and physeal cartilage. Prominent role for gremlin in maintaining hypertrophic chondrocytes in epiphyseal cartilage. Biochem Biophys Res Commun 2009, 390(3):570-576.
22. Nilsson O., Parker E.A., Hegde A., Chau M., Barnes K.M., Baron J. Gradients in bone morphogenetic protein-related gene expression across the growth plate. JEndocrinol 2007, 193(1):75-84.
23. Tardif G., Hum D., Pelletier J.P., Boileau C., Ranger P., Martel-Pelletier J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004, 50(8):2521-2530.
24. Fajardo M., Liu C.J., Egol K. Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study. Clin Orthop Relat Res 2009, 467(12):3071-3078.
25. Sha G., Zhang Y., Zhang C., Wan Y., Zhao Z., Li C., et al. Elevated levels of gremlin-1 in eutopic endometrium and peripheral serum in patients with endometriosis. Fertil Steril 2009, 91(2):350-358.
26. Gagliardi A.D., Kuo E.Y., Raulic S., Wagner G.F., DiMattia G.E. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 2005, 288(1):E92-E105.
27. Yang Y., Liao E. Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA). Med Hypotheses 2007, 68(6):1406-1410.
28. Nakamura Y., Weidinger G., Liang J.O., Aquilina-Beck A., Tamai K., Moon R.T., et al. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. JClin Invest 2007, 117(10):3075-3086.
29. Cui R.R., Huang J., Yi L., Xie H., Zhou H.D., Yuan L.Q., et al. WISP3 suppresses insulin-like growth factor signaling in human chondrocytes. Mol Cell Endocrinol 2007, 279(1-2):1-8.
30. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004, 18(5):1222-1237.
31. Saito T., Ikeda T., Nakamura K., Chung U.I., Kawaguchi H. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep 2007, 8(5):504-509.
32. de Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000, 19(5):389-394.
33. Amano K., Hata K., Sugita A., Takigawa Y., Ono K., Wakabayashi M., et al. Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol Biol Cell 2009, 20(21):4541-4551.
34. Minina E., Wenzel H.M., Kreschel C., Karp S., Gaffield W., McMahon A.P., et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001, 128(22):4523-4534.
35. Fischer J., Dickhut A., Rickert M., Richter W. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum 2010, 62(9):2696-2706.
36. Aigner T., Dietz U., Stoss H., von der Mark K. Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 1995, 73(2):236-243.
37. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010, 339(1):189-195.
38. Ijiri K., Zerbini L.F., Peng H., Otu H.H., Tsuchimochi K., Otero M., et al. Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum 2008, 58(7):2075-2087.
39. Ijiri K., Zerbini L.F., Peng H., Correa R.G., Lu B., Walsh N., et al. Anovel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. JBiol Chem 2005, 280(46):38544-38555.
40. Reinhold M.I., Kapadia R.M., Liao Z., Naski M.C. The Wnt-inducible transcription factor Twist1 inhibits chondrogenesis. JBiol Chem 2006, 281(3):1381-1388.
41. Connerney J., Andreeva V., Leshem Y., Mercado M.A., Dowell K., Yang X., et al. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 2008, 318(2):323-334.
42. Moester M.J., Papapoulos S.E., Lowik C.W., van Bezooijen R.L. Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 2010, 87(2):99-107.
43. Chan B.Y., Fuller E.S., Russell A.K., Smith S.M., Smith M.M., Jackson M.T., et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 2011, 19(7):874-885.
44. van Bezooijen R.L., Bronckers A.L., Gortzak R.A., Hogendoorn P.C., van der Wee-Pals L., Balemans W., et al. Sclerostin in mineralized matrices and van Buchem disease. JDent Res 2009, 88(6):569-574.
45. Keller H., Kneissel M. SOST is a target gene for PTH in bone. Bone 2005, 37(2):148-158.
46. Gerstenfeld L.C., Shapiro F.D. Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. JCell Biochem 1996, 62(1):1-9.
47. Sims N.A., White C.P., Sunn K.L., Thomas G.P., Drummond M.L., Morrison N.A., et al. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 invivo. Mol Endocrinol 1997, 11(11):1695-1708.
48. Ortega N., Wang K., Ferrara N., Werb Z., Vu T.H. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech 2010, 3(3-4):224-235.
49. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. JCell Biochem 2003, 88(5):873-884.
50. Aigner T., Fundel K., Saas J., Gebhard P.M., Haag J., Weiss T., et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006, 54(11):3533-3544.
51. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., Stromberg A.J. Statistical implications of pooling RNA samplesfor microarray experiments. BMC Bioinformatics 2003, 4:26.